Gabriel Leprivier

3.0k citations
35 papers · 1.5k indexed · h-index 18

Gabriel Leprivier

35 papers receiving 1.5k citations

Peers

Gabriel Leprivier
Comparison fields: 5 of 89
  • Molecular Biology 1.2k
  • Cancer Research 524
  • Pulmonary and Respiratory Medicine 297
  • Oncology 208
  • Epidemiology 111
Replace Shuo Qie with:
Shuo Qie United States
Sharanya Sivanand United States
Loredana Moro Italy
Edward L. LaGory United States
Naiara Santana-Codina United States
Javier García‐Bermúdez United States
Hyonchol Jang South Korea
Lingtao Jin United States
Guang‐Zhi Jin China
Suyoun Chung Japan
Gabriel Leprivier relative to Shuo Qie United States Shuo Qie's profile →
Citations per field
00.5×
Shuo Qie · 1×
Citations per year

Countries citing papers authored by Gabriel Leprivier

Since Specialization
Citations

This map shows the geographic impact of Gabriel Leprivier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriel Leprivier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriel Leprivier more than expected).

Fields of papers citing papers by Gabriel Leprivier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabriel Leprivier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriel Leprivier. The network helps show where Gabriel Leprivier may publish in the future.

Co-authorship network of co-authors of Gabriel Leprivier

This figure shows the co-authorship network connecting the top 25 collaborators of Gabriel Leprivier. A scholar is included among the top collaborators of Gabriel Leprivier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabriel Leprivier. Gabriel Leprivier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 6
2 10
3 91
4 70
5 3
6 133
7 76
8 14
9 23
10 20
11 127
12 2
13 98
14 34
15 13
16 1
17 100
18 39
19 29
20 26

About Gabriel Leprivier

Gabriel Leprivier is a scholar working on Cancer Research, Biochemistry and Molecular Biology, having authored 35 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (11 papers), PI3K/AKT/mTOR signaling in cancer (7 papers) and RNA Research and Splicing (7 papers). The work is most often cited by research in Cancer Research (524 citations), Molecular Biology (1.2k citations) and Pulmonary and Respiratory Medicine (297 citations). Gabriel Leprivier has collaborated with scholars based in Germany, Canada and Israel. Frequent co-authors include Barak Rotblat, Poul H. Sorensen, Jonathan Lim, Thomas G. P. Grünewald, Silvia von Karstedt, Alberto Delaidelli, Gian Luca Negri, Debjit Khan, William W. Lockwood and Milena Čolović. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026